RxDoctor Payments Data

Tracy Hilburn

Family · Greencastle, INNPI 1659725430

Payments from drug & device makers

$3,694in general payments, 2019–2025

Across 192 payments — averaging $19.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$547
  • AbbVie$542
  • AstraZeneca$350
  • Lilly USA, LLC$220
  • Novartis$210
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$173
  • plus $2K from 25 others

What the payments were for

  • Food & beverage$3,694100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,694 in reported general payments places this provider in the 85th percentile of 4,392 family providers in Indiana.

See all family providers in Indiana

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide18$26,955
Trelegy ElliptaFluticasone/Umeclidin/Vilanter20$15,642
TrintellixVortioxetine Hydrobromide14$12,398
FarxigaDapagliflozin Propanediol12$11,358
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr15$8,782
Albuterol Sulfate HfaAlbuterol Sulfate72$1,555
Levothyroxine Sodium82$895
Tramadol Hcl29$592
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen38$553
Fluticasone Propionate36$511
Doxycycline Hyclate46$418
Atorvastatin Calcium80$395
Duloxetine Hcl20$383
Gabapentin45$382
Omeprazole40$336

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$220$26,95518 claims
GSKTrelegy Ellipta, Anoro Ellipta$28$24,42435 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$87$12,39814 claims
AstraZenecaFarxiga$350$11,35812 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,392 family providers in Indiana.

Other family in Greencastle

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →